Morphogenesis Inc.: Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting
TAMPA, FL / ACCESSWIRE / May 30, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment
United States Jenene Thomas Morphogenesi Ifx Andrew Brohl Research Institute H Lee Moffitt Cancer Center
Source: finanznachrichten.de